The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Announcement, Press Release PICI Appoints John Connolly as Chief Scientific Officer Research Project CANDEL: A first-of-its-kind data analysis engine for scientific discovery Cancer Research Heroes, Partner Highlight A Science-Driven Partnership Announcement Our Stance on Equality Cancer Research Heroes The Power of Patient Samples Research Project REVIVE: Can we outsmart cancer by learning from the past? Announcement, Press Release PICI Appoints Frederic Pla as Chief Operating Officer